Tag: regulatory alignment

Virtual Reality Tools for Rare Disease Patient Education

August 21, 2025

Virtual Reality Tools for Rare Disease Patient Education Transforming Patient Education in Rare Disease Trials with Virtual Reality The Role of Patient Education in Rare Disease Clinical Trials Effective patient education is central to clinical trial success, particularly in rare disease studies where participants and caregivers often lack prior exposure to research environments. Informed consent…

Data & Technology, Rare and Orphan Disease Trials

Managing Complex Protocols in Ultra-Rare Disease Studies

August 12, 2025

digi

Managing Complex Protocols in Ultra-Rare Disease Studies How to Effectively Manage Complex Protocols in Ultra-Rare Disease Clinical Trials Why Protocol Complexity is Unavoidable in Ultra-Rare Disease Trials Ultra-rare diseases—those affecting fewer than 1 in 50,000 individuals—pose immense challenges for clinical development. Due to limited scientific knowledge, lack of standardized endpoints, and heterogeneous patient presentations, protocols…

Operational Challenges, Rare and Orphan Disease Trials

Stakeholder Buy-In for Adaptive Rare Disease Studies

August 10, 2025

digi

Stakeholder Buy-In for Adaptive Rare Disease Studies Building Stakeholder Consensus for Adaptive Designs in Rare Disease Trials Introduction: The Human Element in Adaptive Trial Success Adaptive trial designs are transforming how we approach rare disease clinical research. These designs allow for protocol modifications based on interim data—enhancing efficiency, flexibility, and ethical oversight. However, their successful…

Adaptive Trial Designs, Rare and Orphan Disease Trials